The South African Species of Rhus L. by S. Schonland

Get full text

THe flight of thunderbolts/ by 223048 Schonland, Basil Ferdinand Jamieson

Treatment in AL Amyloidosis: Moving towards Individualized and Clone-Directed Therapy by Ute Hegenbart, Marc S. Raab, Stefan O. Schönland

Get full text

Allogeneic Transplantation in Multiple Myeloma—Does It Still Have a Place? by Gösta Gahrton, Simona Iacobelli, Laurent Garderet, Ibrahim Yakoub-Agha, Stefan Schönland

Get full text

Cryo-EM structure of an ATTRwt amyloid fibril from systemic non-hereditary transthyretin amyloidosis by Maximilian Steinebrei, Juliane Gottwald, Julian Baur, Christoph Röcken, Ute Hegenbart, Stefan Schönland, Matthias Schmidt

Get full text

Analysis of the complete lambda light chain germline usage in patients with AL amyloidosis and dominant heart or kidney involvement. by Natalie Berghaus, Sarah Schreiner, Martin Granzow, Carsten Müller-Tidow, Ute Hegenbart, Stefan O Schönland, Stefanie Huhn

Get full text

Cryo-EM reveals structural breaks in a patient-derived amyloid fibril from systemic AL amyloidosis by Lynn Radamaker, Julian Baur, Stefanie Huhn, Christian Haupt, Ute Hegenbart, Stefan Schönland, Akanksha Bansal, Matthias Schmidt, Marcus Fändrich

Get full text

First third-generation CAR T cell application targeting CD19 for the treatment of systemic IgM AL amyloidosis with underlying marginal zone lymphoma by Felix Korell, Stefan Schönland, Anita Schmitt, Madelaine Jansen, Kiavasch Farid, Carsten Müller-Tidow, Peter Dreger, Michael Schmitt, Ute Hegenbart

Get full text

Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis by Maximilian Steinebrei, Julian Baur, Anaviggha Pradhan, Niklas Kupfer, Sebastian Wiese, Ute Hegenbart, Stefan O. Schönland, Matthias Schmidt, Marcus Fändrich

Get full text

Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis by Lynn Radamaker, Yin-Hsi Lin, Karthikeyan Annamalai, Stefanie Huhn, Ute Hegenbart, Stefan O. Schönland, Günter Fritz, Matthias Schmidt, Marcus Fändrich

Get full text

Seroconversion Rates After the Second COVID-19 Vaccination in Patients With Systemic Light Chain (AL) amyloidosis by Nora Liebers, Stefan O. Schönland, Claudius Speer, Dominic Edelmann, Paul Schnitzler, Hans-Georg Kräusslich, Carsten Mueller-Tidow, Ute Hegenbart, Sascha Dietrich

Get full text

Prognosis of light chain amyloidosis: a multivariable analysis for survival prediction in patients with cardiac involvement proven by endomyocardial biopsy by Sebastian Greiner, Matthias Aurich, Hugo A Katus, Derliz Mereles, Norbert Frey, Fabian aus dem Siepen, Julian Bucur, Johannes A Vey, Ute Hegenbart, Stefan Schönland

Get full text

Fatal amyloid formation in a patient’s antibody light chain is caused by a single point mutation by Pamina Kazman, Marie-Theres Vielberg, María Daniela Pulido Cendales, Lioba Hunziger, Benedikt Weber, Ute Hegenbart, Martin Zacharias, Rolf Köhler, Stefan Schönland, Michael Groll, Johannes Buchner

Get full text

P914: EFFICACY AND SAFETY OF BELANTAMAB MAFODOTIN MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY LIGHT CHAIN AMYLOIDOSIS: A PHASE 2 STUDY BY THE EUROPEAN MYELOMA NETWORK by E. Kastritis, G. Palladini, M. A. Dimopoulos, A. Jaccard, G. Merlini, F. Theodorakakou, D. Fotiou, M. C. Minnema, A. Wechalekar, S. Gkolfinopoulos, K. Manousou, P. Sonneveld, S. Schönland

Get full text

P899: HOVON 104; LONG TERM FOLLOW-UP OF AUTOLOGOUS STEM CELL TRANSPLANTATION AFTER BORTEZOMIB INDUCTION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED AL AMYLOIDOSIS by Monique Minnema, Kazem Nasserinejad, Ute Hegenbart, Paula Ypma, Ka Lung Wu, Marie José Kersten, Sandra Croockewit, Esther de Waal, Sonja Zweegman, Lidwien Tick, Annemiek Broijl, Stefan Schönland

Get full text

CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma—Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance by Anja Seckinger, Jens Hillengass, Martina Emde, Susanne Beck, Christoph Kimmich, Tobias Dittrich, Michael Hundemer, Anna Jauch, Ute Hegenbart, Marc-Steffen Raab, Anthony D. Ho, Stefan Schönland, Dirk Hose

Get full text

Ruxolitinib is effective in the treatment of a patient with refractory T‐ALL by Sonia Jaramillo, Hannah Hennemann, Peter Horak, Veronica Teleanu, Christoph E. Heilig, Barbara Hutter, Albrecht Stenzinger, Hanno Glimm, Benjamin Goeppert, Carsten Müller‐Tidow, Stefan Fröhling, Stefan Schönland, Richard F. Schlenk

Get full text

S198: EFFICACY AND SAFETY OF BELANTAMAB MAFODOTIN MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY LIGHT CHAIN AMYLOIDOSIS: A PHASE 2 STUDY BY THE EUROPEAN MYELOMA NETWORK by Efstathios Kastritis, Giovanni Palladini, Meletios A. Dimopoulos, Arnaud Jaccard, Giampaolo Merlini, Foteini Theodorakakou, Despina Fotiou, Monique C. Minnema Minnema, Ashutosh Wechalekar, Elena Papachristou, Kyriaki Manousou, Pieter Sonneveld, Stefan Schönland

Get full text

Concurrent light chain amyloidosis and proximal tubulopathy: Insights into different aggregation behavior—A case report by Simone Feurstein, Julian Zoller, Constantin Schwab, Sarah Schreiner, Heiko Mundt, Iris Breitkreutz, Brigitte Schneider, Jörg Beimler, Martin Zeier, Rüdiger Waldherr, Stefan Gröschel, Carsten Müller‐Tidow, Stefan O. Schönland, Ute Hegenbart

Get full text

Magnetization transfer ratio quantifies polyneuropathy in hereditary transthyretin amyloidosis by Jennifer Kollmer, Ute Hegenbart, Christoph Kimmich, Ernst Hund, Jan C. Purrucker, John M. Hayes, Stephen I. Lentz, Georges Sam, Johann M. E. Jende, Stefan O. Schönland, Martin Bendszus, Sabine Heiland, Markus Weiler

Get full text